Noxafil
Generic name: posaconazole (oral/injection)
Drug class: Azole antifungals
Medically reviewed by A Ras MD.
What is Noxafil?
Noxafil (which refers to injection, delayed-release tablets, and oral suspension) and Noxafil PowderMix (for delayed-release oral suspension) are prescription medicines used in adults and children to help prevent or treat fungal infections that can spread throughout your body (invasive fungal infections).
These infections are caused by fungi called Aspergillus or Candida. Noxafil and Noxafil PowderMix are used in people who have an increased chance of getting these infections due to a weak immune system. These include people who have had a hematopoietic stem cell transplantation (bone marrow transplant) with graft versus host disease or those with a low white blood cell count due to chemotherapy for blood cancers (hematologic malignancies).
Description
Noxafil (posaconazole) is an azole antifungal agent. Noxafil is available as an injection solution to be diluted before intravenous administration, delayed-release tablet, oral suspension, and for delayed-release oral suspension intended for oral administration. Noxafil PowderMix for delayed-release oral suspension must be reconstituted before oral administration.
Posaconazole is designated chemically as 4-[4-[4-[4-[[ (3R,5R)-5- (2,4-difluorophenyl)tetrahydro-5- (1H-1,2,4-triazol-1-ylmethyl)-3-furanyl]methoxy]phenyl]-1-piperazinyl]phenyl]-2-[(1S,2S)-1-ethyl-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one with an empirical formula of C37H42F2N8O4 and a molecular weight of 700.8. The chemical structure is:
Noxafil Injection
Noxafil injection is available as a clear colorless to yellow, sterile liquid essentially free of foreign matter. Each vial contains 300 mg of posaconazole and the following inactive ingredients: 6.68 g Betadex Sulfobutyl Ether Sodium (SBECD), 0.0033 g edetate disodium, hydrochloric acid and sodium hydroxide to adjust the pH to 2.6, and water for injection.
Noxafil Delayed-Release Tablets
Noxafil delayed-release tablet is a yellow, coated, oblong tablet containing 100 mg of posaconazole. Each delayed-release tablet contains the inactive ingredients: croscarmellose sodium, hydroxypropylcellulose, hypromellose acetate succinate, iron oxide yellow, Macrogol/PEG 3350, magnesium stearate, microcrystalline cellulose, polyvinyl alcohol partially hydrolyzed, silicon dioxide, talc, and titanium dioxide.
Noxafil Oral Suspension
Noxafil oral suspension is a white, cherry-flavored immediate-release suspension containing 40 mg of posaconazole per mL and the following inactive ingredients: artificial cherry flavor, citric acid monohydrate, glycerin, liquid glucose, polysorbate 80, purified water, simethicone, sodium benzoate, sodium citrate dihydrate, titanium dioxide, and xanthan gum.
Noxafil PowderMix for Delayed-Release Oral Suspension
Noxafil PowderMix for delayed-release oral suspension is supplied as a component of a kit. Each kit contains Noxafil as an off-white to yellowish powder for delayed-release oral suspension, a bottle of mixing liquid, two 3 mL (green) notched tip syringes, two 10 mL (blue) notched tip syringes, two mixing cups, and one bottle adapter for the mixing liquid bottle. Noxafil PowderMix for delayed-release oral suspension contains 300 mg of posaconazole and the following inactive ingredient: hypromellose acetate succinate. The mixing liquid contains: anhydrous citric acid, antifoam Af emulsion, berry citrus sweet flavor, carboxymethylcellulose sodium, carrageenan calcium sulfate trisodium phosphate, glycerin, methylparaben, microcrystalline cellulose, potassium sorbate, propylparaben, purified water, sodium citrate, sodium phosphate monobasic monohydrate, sodium saccharin, sorbitol solution, and xanthan gum. Once reconstituted, the Noxafil PowderMix for delayed-release oral suspension will be cloudy and free of clumps.
Noxafil injection is used for:
- prevention of fungal infections in adults and children 2 years of age and older.
- treatment of fungal infections in adults and children 13 years of age and older.
Noxafil delayed-release tablets are used for:
- prevention of fungal infections in adults and children 2 years of age and older who weigh greater than 88 lbs (40 kg).
- treatment of fungal infections in adults and children 13 years of age and older.
Noxafil oral suspension is used for:
- prevention of fungal infections in adults and children 13 years of age and older.
Noxafil PowderMix for delayed-release oral suspension is used for:
- prevention of fungal infections in children 2 years of age and older who weigh 88 lbs (40 kg) or less.
Noxafil oral suspension is also used to treat a fungal infection called “thrush” caused by Candida in your mouth or throat area. Noxafil oral suspension can be used as the first treatment for thrush, or as another treatment for thrush after itraconazole or fluconazole treatment has not worked.
Noxafil oral suspension is for adults and children 13 years of age and older.
It is not known if Noxafil or Noxafil PowderMix is safe and effective in children under 2 years of age.
Who should not take Noxafil?
Do not take Noxafil or Noxafil PowderMix if you:
- are allergic to posaconazole, any of the ingredients in Noxafil or Noxafil PowderMix, or other azole antifungal medicines. See the end of this leaflet for a complete list of ingredients in Noxafil and Noxafil PowderMix.
- are taking any of the following medicines:
- sirolimus
- pimozide
- quinidine
- certain statin medicines that lower cholesterol (atorvastatin, lovastatin, simvastatin)
- ergot alkaloids (ergotamine, dihydroergotamine)
- are taking Noxafil PowderMix for delayed-release oral suspension and have hereditary fructose intolerance.
Ask your healthcare provider or pharmacist if you are not sure if you are taking any of these medicines.
Do not start taking a new medicine without talking to your healthcare provider or pharmacist.
What should I tell my healthcare provider before taking Noxafil?
Before you take Noxafil or Noxafil PowderMix, tell your healthcare provider if you:
- are taking certain medicines that lower your immune system like cyclosporine or tacrolimus.
- are taking certain drugs for HIV infection, such as ritonavir, atazanavir, efavirenz, or fosamprenavir. Efavirenz and fosamprenavir can cause a decrease in the Noxafil levels in your body. Efavirenz and fosamprenavir should not be taken with Noxafil or Noxafil PowderMix.
- are taking midazolam, a hypnotic and sedative medicine.
- are taking vincristine, vinblastine and other “vinca alkaloids” (medicines used to treat cancer).
- have or had liver problems.
- have or had kidney problems.
- have or had an abnormal heart rate or rhythm, heart problems, or blood circulation problems.
- are pregnant or plan to become pregnant. It is not known if Noxafil will harm your unborn baby.
- are breastfeeding or plan to breastfeed. It is not known if Noxafil passes into your breast milk. You and your healthcare provider should decide if you will take Noxafil or breastfeed. You should not do both.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Noxafil and Noxafil PowderMix can affect the way other medicines work, and other medicines can affect the way Noxafil and Noxafil PowderMix work, and can cause serious side effects.
Especially tell your healthcare provider if you take:
- rifabutin or phenytoin. If you are taking these medicines, you should not take Noxafil delayed-release tablets, Noxafil oral suspension, or Noxafil PowderMix for delayed-release oral suspension.
- cimetidine or esomeprazole. If you are taking these medicines, you should not take Noxafil oral suspension.
Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure.
Know the medicines you take. Keep a list of them with you to show your healthcare provider or pharmacist when you get a new medicine.
How should I take Noxafil?
- Do not switch between Noxafil oral suspension and Noxafil delayed-release tablets or Noxafil PowderMix for delayed-release oral suspension.
- Take Noxafil or Noxafil PowderMix exactly as your healthcare provider tells you to take it.
- Your healthcare provider will tell you how much Noxafil or Noxafil PowderMix to take and when to take it.
- Take Noxafil or Noxafil PowderMix for as long as your healthcare provider tells you to take it.
- If you take too much Noxafil or Noxafil PowderMix, call your healthcare provider or go to the nearest hospital emergency room right away.
- Noxafil injection is usually given over 30 to 90 minutes through a plastic tube placed in your vein.
- Noxafil delayed-release tablets:
- Take Noxafil delayed-release tablets with or without food.
- Take Noxafil delayed-release tablets whole. Do not break, crush, or chew Noxafil delayed-release tablets before swallowing. If you cannot swallow Noxafil delayed-release tablets whole, tell your healthcare provider. You may need a different medicine.
- If you miss a dose, take it as soon as you remember and then take your next scheduled dose at its regular time. If it is within 12 hours of your next dose, do not take the missed dose. Skip the missed dose and go back to your regular schedule. Do not double your next dose or take more than your prescribed dose.
- Noxafil oral suspension:
- Shake Noxafil oral suspension well before use.
- Take each dose of Noxafil oral suspension during or within 20 minutes after a full meal. If you cannot eat a full meal, take each dose of Noxafil oral suspension with a liquid nutritional supplement or an acidic carbonated beverage, like ginger ale.
- A measured dosing spoon comes with your Noxafil oral suspension and is marked for doses of 2.5 mL and 5 mL. See Figure A.
- Rinse the spoon with water after each dose of Noxafil oral suspension and before you store it away.
- If you miss a dose, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and go back to the regular dosing schedule. Do not take a double dose to make up for the missed dose.
Figure A
- Noxafil PowderMix for delayed-release oral suspension:
- Before giving the first dose of Noxafil PowderMix for delayed-release oral suspension, read the Instructions for Use booklet that comes with Noxafil PowderMix for delayed-release oral suspension for information about the correct way to mix and give a dose of Noxafil PowderMix for delayed-release oral suspension to your child. Keep the booklet and follow it each time you prepare the medicine. Bring this booklet to your child’s appointments.
- If you have questions about how to mix or give Noxafil PowderMix, talk with your doctor or pharmacist.
- Only use the mixing liquid that comes with the kit to prepare Noxafil PowderMix.
- Once mixed, measure the prescribed dose with notched tip syringe provided with the kit. Only use the notched tip syringes that come with the kit to prepare and administer the medicine.
- Give the dose within 1 hour of mixing the suspension. Give with food.
- If your child does not take all of the prescribed dose or spits some of it out, call your doctor to find out what to do.
Follow the instructions from your healthcare provider on how much Noxafil or Noxafil PowderMix you should take and when to take it.
What are the possible side effects of Noxafil?
Noxafil or Noxafil PowderMix may cause serious side effects, including:
- drug interactions with cyclosporine or tacrolimus. If you take Noxafil or Noxafil PowderMix with cyclosporine or tacrolimus, your blood levels of cyclosporine or tacrolimus may increase. Serious side effects can happen in your kidney or brain if you have high levels of cyclosporine or tacrolimus in your blood. Your healthcare provider should do blood tests to check your levels of cyclosporine or tacrolimus if you are taking these medicines while taking Noxafil or Noxafil PowderMix. Tell your healthcare provider right away if you have swelling in your arm or leg or shortness of breath.
- problems with the electrical system of your heart (arrhythmias and QTc prolongation). Certain medicines used to treat fungus called azoles, including posaconazole, the active ingredient in Noxafil and Noxafil PowderMix, may cause heart rhythm problems. People who have certain heart problems or who take certain medicines have a higher chance for this problem. Tell your healthcare provider right away if your heartbeat becomes fast or irregular.
- liver problems. Some people who also have other serious medical problems may have severe liver problems that may lead to death, especially if you take certain doses of Noxafil or Noxafil PowderMix. Your healthcare provider should do blood tests to check your liver while you are taking Noxafil or Noxafil PowderMix. Call your healthcare provider right away if you have any of the following symptoms of liver problems:
- itchy skin
- nausea or vomiting
- yellowing of your eyes
- feeling very tired
- flu-like symptoms
- increased amounts of midazolam in your blood. If you take Noxafil or Noxafil PowderMix with midazolam, Noxafil or Noxafil PowderMix increases the amount of midazolam in your blood. This can make your sleepiness last longer. Your healthcare provider should check you closely for side effects if you take midazolam with Noxafil or Noxafil PowderMix.
The most common side effects of Noxafil in adults include:
- diarrhea
- nausea
- fever
- vomiting
- headache
- coughing
- low potassium levels in the blood
The most common side effects of Noxafil injection and Noxafil PowderMix in children include:
- fever
- fever with low white blood cell count (febrile neutropenia)
- vomiting
- redness and sores of the lining of the mouth, lips, throat, stomach, and genitals (mucositis or stomatitis)
- itching
- high blood pressure
- low potassium levels in the blood
If you take Noxafil delayed-release tablets, Noxafil oral suspension, or Noxafil PowderMix for delayed-release oral suspension, tell your healthcare provider right away if you have diarrhea or vomiting.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of Noxafil or Noxafil PowderMix. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
General information about the safe and effective use of Noxafil
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use Noxafil or Noxafil PowderMix for a condition for which it was not prescribed. Do not give Noxafil or Noxafil PowderMix to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about Noxafil or Noxafil PowderMix that is written for health professionals.
How should I store Noxafil?
Noxafil injection
- Store Noxafil injection refrigerated at 36°F to 46°F (2°C to 8°C).
Noxafil delayed-release tablets
- Store Noxafil delayed-release tablets at room temperature between 68°F to 77°F (20°C to 25°C).
Noxafil oral suspension
- Store Noxafil oral suspension at room temperature between 68°F to 77°F (20°C to 25°C).
- Do not freeze Noxafil oral suspension.
Noxafil PowderMix for delayed-release oral suspension
- Store the entire kit at room temperature between 68°F to 77°F (20°C to 25°C) in a clean, dry place.
- Do not open the foil packet until ready for use.
Safely throw away medicine that is out of date or no longer needed.
Keep Noxafil and Noxafil PowderMix and all medicines out of the reach of children.
What are the ingredients in Noxafil?
Active ingredient: posaconazole
Inactive ingredients:
Noxafil injection: Betadex Sulfobutyl Ether Sodium (SBECD), edetate sodium, hydrochloric acid, sodium hydroxide, and water for injection.
Noxafil delayed-release tablets: croscarmellose sodium, hydroxypropylcellulose, hypromellose acetate succinate, iron oxide yellow, Macrogol/PEG 3350, magnesium stearate, microcrystalline cellulose, polyvinyl alcohol partially hydrolyzed, silicon dioxide, talc, and titanium dioxide.
Noxafil oral suspension: artificial cherry flavor, citric acid monohydrate, glycerin, liquid glucose, polysorbate 80, purified water, simethicone, sodium benzoate, sodium citrate dihydrate, titanium dioxide, and xanthan gum.
Noxafil PowderMix for delayed-release oral suspension: hypromellose acetate succinate.
The mixing liquid contains: anhydrous citric acid, antifoam Af emulsion, berry citrus sweet flavor, carboxymethylcellulose sodium, carrageenan calcium sulfate trisodium phosphate, glycerin, methylparaben, microcrystalline cellulose, potassium sorbate, propylparaben, purified water, sodium citrate, sodium phosphate monobasic monohydrate, sodium saccharin, sorbitol solution, and xanthan gum.
For more information, go to www.noxafil.com or call 1-800-672-6372.
Instructions for use for Noxafil
Noxafil PowderMix (posaconazole)
for delayed-release oral suspension
For caregivers and healthcare providers of toddlers and children
Before you start
|
Note: Put your child in a safe place. You will need both hands to prepare Noxafil PowderMix. Wash your hands with soap and water before preparing Noxafil PowderMix. |
- The amount of Noxafil PowderMix you give depends on your child’s weight. Your healthcare provider will tell you the right dose to give your child. Be sure to keep your healthcare provider’s appointments so you get new dosing information as your child grows.
- This booklet tells you how to:
- Make the Noxafil PowderMix into a liquid form.
- Measure the right dose using the included notched-tip oral syringe. Only use the notched-tip syringes supplied
with the kit. Do not use other oral syringes. - Give the Noxafil PowderMix to your child.
- Clean up.
Note before adding Noxafil PowderMix: Make sure you and your child are ready! If you do not use Noxafil PowderMix within 1 hour, you will need to throw it away and start over. |
Note: If you have any questions, call your healthcare provider. |
Kit contents
|
|
||
|
|
||
|
|
||
|
|
2 blue (10 mL) syringes | 2 green (3 mL) syringes |
The kit has an extra cup and set of syringes in case one is lost or damaged. Do not use any damaged cups or syringes. |
Get to know the oral syringes
|
- Look for the number on the measuring scale that matches the amount of mixing liquid or Noxafil PowderMix that you need.
- Be sure to follow the directions in this booklet to remove air bubbles from the syringe. Air bubbles can affect the amount of medicine that the child gets.
Step 1. Get the mixing liquid ready.
Important: Noxafil PowderMix needs to be prepared using the mixing liquid. Do not mix Noxafil PowderMix with milk, juice, or water. |
When you use the mixing liquid for the first time:
- Open the bottle and remove the safety seal.
- Place the bottle adapter on top of the bottle with the small hole facing up.
- Push the bottle adapter all the way down.
- After it is in place, the bottle adapter stays in the bottle.
- Put the cap back on the bottle.
Step 2. Gather all your supplies and put on a clean surface.
Note: Put your child in a safe place. You will need both hands to prepare Noxafil PowderMix. Wash your hands with soap and water before preparing Noxafil PowderMix. |
1 mixing cup (Using the tab on the mixing cup, pull open the lid.) |
1 packet of Noxafil PowderMix powder |
Mixing liquid | 2 syringes (Have 1 of each size ready, but you may only use 1, depending on the dose.) |
Scissors (not included with kit: use sharp household scissors or kitchen scissors) |
The Noxafil PowderMix box has a mixing cup holder inside to help tilt the cup when you are measuring the dose. |
Step 3. Add Noxafil PowderMix to the mixing cup
Note before adding Noxafil PowderMix: Make sure you and your child are ready! If you do not use Noxafil PowderMix within 1 hour, you will need to throw it away and start over. |
|
|
|
Step 4. Shake the mixing liquid bottle.
|
Step 5. Fill the blue syringe with 9 mL of mixing liquid.
|
Step 6. Check for air bubbles.
|
|
|
Step 7. Add the 9 mL of mixing liquid to the Noxafil PowderMix.
- Add the 9 mL of mixing liquid to the Noxafil PowderMix in the mixing cup by pushing all the way down on the plunger.
Step 8. Mix the Noxafil PowderMix.
|
|
|
Step 9. Check your prescription label.
|
Note: The dose may change each time you go to the healthcare provider, so make sure you have all the recent information. Be sure to go to all of your child’s healthcare provider appointments so your child gets the right dose. |
Step 10. Choose the syringe you need.
Note: Only use the syringes provided in the kit. |
For 1 mL to 3 mL Green |
For 3 mL to 10 mL Blue |
- Then find the mL mark on the syringe that matches your child’s dose.
Step 11. Measure the Noxafil PowderMix.
|
Important: You will not use all of the Noxafil PowderMix. There will be some left over in the mixing cup. |
Step 12. Check for air bubbles.
|
|
|
Step 13. Give the Noxafil PowderMix to your child.
|
Important:
|
Step 14. Clean the cup and syringes.
Note: Syringes and mixing cups should be reused. Do not throw away syringes and mixing cups provided until all the Noxafil PowderMix packets are used. |
|
Step 15. After all packets of Noxafil PowderMix have been used.
- After you have used the last Noxafil PowderMix packet in this box, you will have leftover mixing liquid in the bottle. Throw away the leftover mixing liquid and all components of the kit.
How should I store Noxafil PowderMix?
- Store the entire kit at room temperature between 68°F to 77°F (20°C to 25°C) in a clean, dry place.
- Keep the mixing liquid at room temperature.
- Do not open the Noxafil PowderMix packet until you are ready to mix a dose.
Keep Noxafil PowderMix and all medicines out of the reach of children.
Label
PRINCIPAL DISPLAY PANEL – 105 ML BOTTLE CARTON
- NDC 0085-1328-01
105 mL - NOXAFIL®
(posaconazole) - Oral Suspension
- 200 mg/5 mL
- Each mL contains: 40 mg posaconazole.
- Attention: Noxafil Oral Suspension and
Delayed-Release Tablets are NOT
interchangeable due to differences in the
dosing of each formulation. - SHAKE WELL BEFORE EACH USE.
- Take with a meal, or a nutritional supplement,
or an acidic carbonated beverage. - Carton contains measured dosing spoon.
- Rx only
PRINCIPAL DISPLAY PANEL – 60 TABLET BOTTLE LABEL
- NDC 0085-4324-02
- Noxafil®
(posaconazole)
delayed-release tablets - 100 mg
- Each tablet contains 100 mg posaconazole.
- Attention: Noxafil Oral Suspension and Delayed-
Release Tablets are NOT interchangeable due to
differences in the dosing of each formulation. - Rx only
- 60 Tablets
PRINCIPAL DISPLAY PANEL – 16.7 ML VIAL CARTON
- NDC 0085-4331-01
- Noxafil®
(posaconazole)
Injection - 300 mg/16.7 mL
(18 mg/mL) - For Intravenous Use Only
- Requires further dilution prior to infusion.
- Rx only
Sterile Single-Dose Vial
Discard Unused Portion
PRINCIPAL DISPLAY PANEL – 300 MG CARTON
- NDC 0085-2224-02
- Noxafil® PowderMix
(posaconazole) for
Delayed-Release Oral Suspension - 300 mg
- For Pediatric Use
For Oral Administration Only - Each packet contains 300 mg posaconazole.
- Attention: Noxafil PowderMix for Delayed-Release Oral Suspension is NOT
substitutable with Noxafil Oral Suspension due to differences in the
dosing of each formulation. - Use only the notched-tip syringes and mixing liquid provided with this kit.
- Rx only
8 packets - Multi-Dose Kit A
Additional notched-tip syringes are provided in
Package B with this kit.
DIRECTIONS FOR USE:
See instructions for use booklet and prescribing
information for additional information.